# LEXICON PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:481f3104-140b-4121-9055-f6803dba7825 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/lexicon-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 11 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-12T02:56:29.077205+00:00 | | Last reviewed | 2026-10-12T02:56:29.077205+00:00 | ## Identity - Legal name: LEXICON PHARMACEUTICALS, INC. - Display name: LEXICON PHARMACEUTICALS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-12T03:20:54.061185+00:00 | | Completeness | 0.409 | | Record Quality | 0.85 | | Directors | 7 | | Committees | 2 | | Governance events | 17 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Christopher J. Sobecki: Director. Status: current. Independent: false. Since: 2007-01-01. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:5 - Diane E. Sullivan: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member). claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:6 - Ivan H. Cheung: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (member). claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:7 - Michael S. Exton, Ph.D.: Director. Status: current. Independent: false. Since: 2024-01-01. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:8 - Philippe J. Amouyal: Director. Status: current. Independent: false. Since: 2007-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:9 - Raymond Debbane: Director. Status: current. Independent: false. Since: 2007-01-01. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:10 - Samuel L. Barker, Ph.D.: Director. Status: current. Independent: true. Since: 2000-01-01. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:11 ## Committees - Audit (audit). Chair: NOT_PUBLISHED. Members: Diane E. Sullivan (member, current); Ivan H. Cheung (member, current). committee_id=alpha:committee:lexicon-pharmaceuticals-inc:audit - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Philippe J. Amouyal (member, current). committee_id=alpha:committee:lexicon-pharmaceuticals-inc:compensation ## Executive leadership - Brian T. Crum: Senior Vice President and General Counsel [GC]. Status: current. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:12 - Craig B. Granowitz, M.D., Ph.D.: Senior Vice President and Chief Medical Officer. Status: current. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:13 - Lisa M. DeFrancesco: Senior Vice President, Investor Relations and Corporate Communications. Status: current. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:14 - Michael S. Exton, Ph.D.: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:15 - Rachel Y. Martens: Senior Vice President, Partnerships and Corporate Strategy. Status: current. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:16 - Scott M. Coiante: Senior Vice President and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:17 - Suma Gopinathan, M.S., Ph.D.: Senior Vice President, Discovery. Status: current. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:18 - Wendy E. McDermott: Senior Vice President, Human Resources. Status: current. claim_id=alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:19 ## Governance events - GC_CHANGED: Brian T. Crum executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:mfm9z31aj2gi5 - EXECUTIVE_APPOINTED: Craig B. Granowitz, M.D., Ph.D. executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:1g8a5jy1wkmqh0 - EXECUTIVE_APPOINTED: Lisa M. DeFrancesco executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:1mbcwo31hnotnp - CEO_CHANGED: Michael S. Exton, Ph.D. executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:195r3ym1f1yzw0 - EXECUTIVE_APPOINTED: Rachel Y. Martens executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:147x1f9q2ijaz - CFO_CHANGED: Scott M. Coiante executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:ihc0g68pa9kc - EXECUTIVE_APPOINTED: Suma Gopinathan, M.S., Ph.D. executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:137xo5ggoqama - EXECUTIVE_APPOINTED: Wendy E. McDermott executive of LEXICON PHARMACEUTICALS, INC., effective 2026-03-05. Effective: 2026-03-05. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:71j1ad1qdlibz - DIRECTOR_APPOINTED: Ivan H. Cheung seat on LEXICON PHARMACEUTICALS, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:1amw1n9qle1pb - DIRECTOR_APPOINTED: Michael S. Exton, Ph.D. seat on LEXICON PHARMACEUTICALS, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:164k9mgwdffhw - DIRECTOR_APPOINTED: Diane E. Sullivan seat on LEXICON PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:1mzba1t1lw64rx - COMMITTEE_MEMBER_ADDED: Diane E. Sullivan member of Audit, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:r84iach5u9si - DIRECTOR_APPOINTED: Christopher J. Sobecki seat on LEXICON PHARMACEUTICALS, INC., effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:b1278u7riud0 - DIRECTOR_APPOINTED: Philippe J. Amouyal seat on LEXICON PHARMACEUTICALS, INC., effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:1bhalqa264a94 - DIRECTOR_APPOINTED: Raymond Debbane seat on LEXICON PHARMACEUTICALS, INC., effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:b6potw1r51lss - COMMITTEE_MEMBER_ADDED: Philippe J. Amouyal member of Compensation, effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:dazw9yl7oy4i - DIRECTOR_APPOINTED: Samuel L. Barker, Ph.D. seat on LEXICON PHARMACEUTICALS, INC., effective 2000-01-01. Effective: 2000-01-01. Detected: 2026-10-12T02:56:29.077205+00:00. event_id=alpha:event:transition:vnzdwe34rmk2 ## Scoped resources - `alpha://company/lexicon-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record - `alpha://company/lexicon-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/lexicon-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/lexicon-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=board - `alpha://company/lexicon-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/lexicon-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/lexicon-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/lexicon-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/lexicon-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/lexicon-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/lexicon-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/lexicon-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/lexicon-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/lexicon-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/lexicon-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/lexicon-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/lexicon-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/lexicon-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/lexicon-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/lexicon-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=events - `alpha://company/lexicon-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/lexicon-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/lexicon-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:diane-e-sullivan","name":"Diane E. Sullivan"},"source_id":"board_seats"}` - Claim alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:ivan-h-cheung","name":"Ivan H. Cheung"},"source_id":"board_seats"}` - Claim alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:philippe-j-amouyal","name":"Philippe J. Amouyal"},"source_id":"board_seats"}` ## Leadership - Christopher J. Sobecki: Director. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:5. Valid from: 2007-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d. - Diane E. Sullivan: Director, Audit. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d. - Ivan H. Cheung: Director, Audit. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:7. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d. - Michael S. Exton, Ph.D.: Director. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d. - Philippe J. Amouyal: Director, Compensation. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:9. Valid from: 2007-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d. - Raymond Debbane: Director. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:10. Valid from: 2007-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d. - Samuel L. Barker, Ph.D.: Director. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:11. Valid from: 2000-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d. - Brian T. Crum: Senior Vice President and General Counsel. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:12. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:48351126989a1f9050e815dc3a7c5a5590c97808cca94478ebeb26cfe10dcf49. - Craig B. Granowitz, M.D., Ph.D.: Senior Vice President and Chief Medical Officer. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:13. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a80cd2ca439437d991f1a36a53a5a8c8e499eaa87367ef95d51510459185a06d. - Lisa M. DeFrancesco: Senior Vice President, Investor Relations and Corporate Communications. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:14. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fc4df8a67d466cb52f4e44a73ec8d21378aac615086ef68b79dbacfb577fbff9. - Michael S. Exton, Ph.D.: Chief Executive Officer and Director. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:15. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b1920fd7f205247534925401074b47a3bceab3c9a6b7ff0cc574e26493f11971. - Rachel Y. Martens: Senior Vice President, Partnerships and Corporate Strategy. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:16. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9eff99ddff19a655ffae85b498c0762cab7132875988233d6486ec1279e6f5cc. - Scott M. Coiante: Senior Vice President and Chief Financial Officer. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:17. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:05ac497613ce0ea726a5a78fa7cc6cc4840ccd230d7b54c23525860c90ce3464. - Suma Gopinathan, M.S., Ph.D.: Senior Vice President, Discovery. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:18. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ff8f23fa6cce525eb1a943dd708a4bcf18320f34f61b032b729efd8923fa8ad2. - Wendy E. McDermott: Senior Vice President, Human Resources. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:leadership_role:19. Valid from: 2026-03-05. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1fbb5ffffe3010c7f4915fc4a348addcce7e51ab8964e98ba72aeb46dded5fa5. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Diane E. Sullivan; Ivan H. Cheung. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b. - Compensation: Chair not stated; Members Philippe J. Amouyal. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - LEXICON PHARMACEUTICALS, INC.. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8f851c4cbe45826b506103fa1b4b3d023deeafb752f480baf69d6daf0a70d829. ## Entity Status - Public listing published. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8f851c4cbe45826b506103fa1b4b3d023deeafb752f480baf69d6daf0a70d829. ## Published Fact - US. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8f851c4cbe45826b506103fa1b4b3d023deeafb752f480baf69d6daf0a70d829. ## Committee Appointment - Diane E. Sullivan: member, Audit. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b. - Ivan H. Cheung: member, Audit. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b. - Philippe J. Amouyal: member, Compensation. Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b. ## Security Listing - LXRX (NASDAQ). Claim: alpha:claim:company:481f3104-140b-4121-9055-f6803dba7825:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8f851c4cbe45826b506103fa1b4b3d023deeafb752f480baf69d6daf0a70d829. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:8f851c4cbe45826b506103fa1b4b3d023deeafb752f480baf69d6daf0a70d829: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc). - alpha:projection-evidence:document:d2c75fcd9455aff0f6e0e5a58be9a9c861c7150585c89a6a5a535d8bfd1ebe1d: [LEXICON PHARMACEUTICALS, INC. DEF 14A 2026-03-16](https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm). - alpha:projection-evidence:document:48351126989a1f9050e815dc3a7c5a5590c97808cca94478ebeb26cfe10dcf49: [LXRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm). - alpha:projection-evidence:document:a80cd2ca439437d991f1a36a53a5a8c8e499eaa87367ef95d51510459185a06d: [LXRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm). - alpha:projection-evidence:document:fc4df8a67d466cb52f4e44a73ec8d21378aac615086ef68b79dbacfb577fbff9: [LXRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm). - alpha:projection-evidence:document:b1920fd7f205247534925401074b47a3bceab3c9a6b7ff0cc574e26493f11971: [LXRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm). - alpha:projection-evidence:document:9eff99ddff19a655ffae85b498c0762cab7132875988233d6486ec1279e6f5cc: [LXRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm). - alpha:projection-evidence:document:05ac497613ce0ea726a5a78fa7cc6cc4840ccd230d7b54c23525860c90ce3464: [LXRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm). - alpha:projection-evidence:document:ff8f23fa6cce525eb1a943dd708a4bcf18320f34f61b032b729efd8923fa8ad2: [LXRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm). - alpha:projection-evidence:document:1fbb5ffffe3010c7f4915fc4a348addcce7e51ab8964e98ba72aeb46dded5fa5: [LXRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm). - alpha:projection-evidence:b58577731f64f97d28d9d62a5fe1499c3709304af17f5f28215161b874d4c73b: [Audit](https://www.sec.gov/Archives/edgar/data/1062822/000106282226000056/lxrx-20260316.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/lexicon-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/lexicon-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/lexicon-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/lexicon-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-12T03:20:53.881823+00:00; recorded 2026-10-12T03:20:53.881823+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.